The ability of animal studies to predict human safety has been evaluated by global information analytics business, Elsevier, through big data analysis of adverse events reported to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA).
Data analysis
More than 1.6 million adverse events were looked at that had been reported for both humans and the five most commonly used animals in regulatory documents. These reports related to documentation for over 3,000 approved drugs and formulations.